NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035

INDUSTRY : Pharmaceuticals

Glenmark Pharmaceuticals Ltd.

Mid-range Performer

350.75 -0.15(-0.04%)

47.4% Fall from 52W High

Volume: 1.1M

NSEJan 24, 2020 15:31

Check Buy or Sell


Fetching latest news from server
  • Stock Price (346.8) crossed above 30 Day SMA (341.72) on 09 January, 2020
  • Month Change by 24.31% (Crossed threshold 20%) on 12 December, 2019
  • Geojit BNP Paribas upgraded Glenmark Pharmaceuticals Ltd. to Hold with a price target of 366.0 on 25 Nov, 2019.
  • Day volume (39631542.0) was 878% of the Month Average Volume (4513076.0) on 18 November, 2019
  • Stock Price (365.55) crossed above 50 Day SMA (327.39) on 18 November, 2019
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
Sept. 19, 20192.00FINAL-
Sept. 19, 20182.00FINAL-
Sept. 20, 20172.00FINAL-
Aug. 3, 20162.00FINAL-
Sept. 10, 20152.00FINAL-
All dividends by GLENMARK
Ex-Date Dividend Bonus Ratio Record Date
March 4, 20051:1-
All bonuses by GLENMARK
Ex-Date Dividend Old FVNew FV Record Date
Sept. 10, 200721-
Oct. 23, 2003102Oct. 31, 2003
All splits by GLENMARK